Frequency, risk factors, and outcomes of vancomycin-resistant enterococcus colonization and infection in patients with newly diagnosed acute leukemia: Different patterns in patients with acute myelogenous and acute lymphoblastic leukemia

Infection Control and Hospital Epidemiology

Volumn 36, Issue 1, 2015, Pages 47-53

  Ford, Clyde D ^a   Lopansri, Bert K ^b   Haydoura, Souha ^b   Snow, Greg ^a   Dascomb, Kristin K ^b   Asch, Julie ^a   Petersen, Finn Bo ^a   Burke, John P ^b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMPHOTERICIN; CARBAPENEM DERIVATIVE; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; DAPTOMYCIN; ECHINOCANDIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN DERIVATIVE; PYRROLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CONTROLLED STUDY; DIARRHEA; DRUG USE; FEMALE; HOSPITAL COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; MORTALITY; NEUTROPENIA; OVERALL SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS; VERY ELDERLY; ADOLESCENT; BACTEREMIA; CLASSIFICATION; ECONOMICS; FEBRILE NEUTROPENIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HETEROZYGOTE; LEUKEMIA, MYELOID, ACUTE; MICROBIOLOGY; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; CARBAPENEMS; CARRIER STATE; DIARRHEA; FEBRILE NEUTROPENIA; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LENGTH OF STAY; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MOLECULAR TYPING; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN-RESISTANT ENTEROCOCCI; YOUNG ADULT;

EID: 84922793788     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1017/ice.2014.3     Document Type: Article

References (20)

1. Butler AM, Olsen MA, Merz LR, et al. The attributable costs of enterococcal bloodstream infections in a non-surgical hospital cohort. Infect Control Hosp Epidemiol 2010;31:28–35.
2. Vydra J, Shanley RM, George I, et al. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55:764–770.
3. Worth LJ, Thursky KA, Seymour JF, Slavin MA. Vancomycinresistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007;79:226–233.
4. Bossaer JB, Hall PD, Garrett-Mayer E. Incidence of vancomycinresistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE. Support Care Cancer 2011;19:231–237.
5. Colderwood MS, Mauer A, Tolentino J, et al. Epidemiology of vancomycin-resistant enterococci among patients on an adult stem cell transplant unit: observations from an active surveillance program. Infect Control Hosp Epidemiol 2008;29:1019–1025.
6. Almyroudis NG, Lesse AJ, Hahn T, et al. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies. Infect Control Hosp Epidemiol 2011;32:490–496.
7. Bonten MJM, Slaughter S, Ambergen AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci. Arch Intern Med 1998;158:1127–1132.
8. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Annals Intern Med 1992;117: 112–116.
9. Batistao DWdF, Gontijo-Filho PPG, Conceicao N, de Oliveira AG, Ribas RM. Risk factors for vancomycin-resistant enterococci colonization in critically ill patients. Mern Inst Oswaldo Cruz, Rio de Janeiro 2012;107:57–63.
10. Yoon KY, Lee SE, Lee J, Kin HJ, et al. Risk factors for prolonged carriage of vancomycin-resistant Enterococcus faecium among patients in intensive care units: a case-control study. J Antimicrob Chemother 2011;66:1831–1838.
11. McKinnell JA, Kunz DF, Chamot E, et al. Association between vancomycin-resistant enterococci bacteremia and ceftriaxone usage. Infect Control Hosp Epidemiol 2012;33:718–724.
12. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001;135:175–183.
13. Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients. Infect Control Hosp Epidemiol 2007;28:1054–1059.
14. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:1925–1932.
15. Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012;55: 905–914.
16. Olivier CN, Blake RK, Steed LL, Salgado CD. Risk of vancomycinresistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 2008;29:404–409.
17. Lodise TP, McKinnon PS, Tam VH, Rybak MJ. Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center. Clin Infect Dis 2002; 34:922–929.
18. DiazGranados CA, Jernigan JA. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005;191:588–595.
19. Zirakzadeh A, Gastineau DA, Mandrekar JN, Burke JP, Johnston PB, Patel R. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2008;41:385–392.
20. Dress M, Snydman DR, Schmid CH, et al. Prior environmental contamination increases the risk of acquisition of vancomycinresistant enterococci. Clin Infect Dis 2008;46:678–685.